{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:41Z","timestamp":1793173241845,"version":"4.5.0"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Diagn Lab Immunol"],"published-print":{"date-parts":[[1999,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The decay of maternally derived antibodies to measles, mumps, and rubella viruses in Swiss infants was studied in order to determine the optimal time for vaccination. A total of 500 serum or plasma samples from infants up to 2 years of age were tested by enzyme-linked immunosorbent assay and fluorescent-antibody testing. The decline of antibody prevalence was slowest against the measles virus. By 9 to 12 months of age, only 5 of 58 (8.6%; 95% CI, 2.9 to 19.0) infants were antibody positive for the measles virus, and only 2 had levels above 200 mIU\/ml. Mumps and rubella virus antibody seropositivity was lowest at 9 to 12 months of age with 3 of 58 (5.2%; 95% CI, 1.1 to 14.4) infants and at 12 to 15 months with 1 of 48 (2.1%; 95% CI, 0.1 to 11.1) infants, respectively. Concentrations of passively acquired antibodies decreased rapidly within the first 6 months of life. We observed no significant differences in antibody prevalence or concentration according to gender in any age group. In conclusion, MMR vaccination at 12 instead of 15 months of age could reduce the pool of susceptible subjects in infancy and support the efforts to eliminate these infections, particularly in combination with a second vaccine dose before school entry.<\/jats:p>","DOI":"10.1128\/cdli.6.6.868-871.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T19:24:00Z","timestamp":1577820240000},"page":"868-871","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":80,"title":["Decay of Passively Acquired Maternal Antibodies against Measles, Mumps, and Rubella Viruses"],"prefix":"10.1128","volume":"6","author":[{"given":"Corina","family":"Nicoara","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Institute for Medical Microbiology, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Za\u0308ch","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institute for Medical Microbiology, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Trachsel","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institute for Medical Microbiology, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Germann","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institute for Medical Microbiology, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Matter","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Institute for Medical Microbiology, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00499466"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S002217240002893X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800057976"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800059203"},{"key":"e_1_3_2_6_2","first-page":"378","article-title":"Measles\u2014United States, 1992.","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","unstructured":"Centers for Disease Control and Prevention Measles\u2014United States, 1992. Morbid. Mortal. Weekly Rep. 42 1993 378 381","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_7_2","first-page":"766","article-title":"Measles outbreak\u2014southwestern Utah, 1996.","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention Measles outbreak\u2014southwestern Utah, 1996. Morbid. Mortal. Weekly Rep. 46 1997 766 769","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-1157(75)90041-4"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/18.1.264"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199511000-00008"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800058441"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.97.2.232"},{"key":"e_1_3_2_13_2","unstructured":"Diem\nK.\nLentner\nC.\nDocumenta Geigy. Wissenschaftliche Tabellen.\n1968\nJ. R. Geigy SA\nBasel Switzerland"},{"key":"e_1_3_2_14_2","unstructured":"Fakult\u00e4re Instanz f\u00fcr Allgemeinmedizin and Bundesamt f\u00fcr Gesundheit\nSentinella 1997.\nAnnual report of the Swiss Sentinel Surveillance Network.\n1999\nSwiss Federal Office of Public Health\nBern Switzerland"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2807\/esm.02.11.00183-en"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549609027163"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198508293130904"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.93.6.939"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890450220"},{"key":"e_1_3_2_20_2","first-page":"145","article-title":"Loss of maternal measles antibody in black South African infants in the first year of life\u2014implications for age of vaccination.","volume":"79","author":"Kiepiela P.","year":"1991","unstructured":"Kiepiela P. Coovadia H. M. Loening W. E. Coward P. Abdool Karim S. S. Loss of maternal measles antibody in black South African infants in the first year of life\u2014implications for age of vaccination. S. Afr. Med. J. 79 1991 145 148","journal-title":"S. Afr. Med. J."},{"key":"e_1_3_2_21_2","unstructured":"King\nG.\nMarkowitz\nL.\nBurns\nS.\nHeath\nJ.\nNordin\nJ.\nBellini\nW.\nA comparison of seroconversion rates to measles vaccine of children vaccinated at 9 12 or 15 months of age abstr. H-108.\nAbstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy.\n1994\nAmerican Society for Microbiology\nWashington D.C."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)81039-3"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.2807\/esm.03.12.00112-en"},{"key":"e_1_3_2_24_2","first-page":"447","article-title":"Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.","volume":"96","author":"Maldonado Y. A.","year":"1995","unstructured":"Maldonado Y. A. Lawrence E. C. De Hovitz R. Hartzell H. Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96 1995 447 450","journal-title":"Pediatrics"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.49.Suppl_1.4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719435"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007326621525"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/513967"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1980020304"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800029186"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199207000-00004"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312101"},{"key":"e_1_3_2_33_2","first-page":"139","article-title":"Annual report on important infectious diseases in Germany. Part 5. Vaccine preventable diseases: diphtheria, tetanus, poliomyelitis, pertussis, measles, mumps, and rubella.","volume":"19","author":"Robert Koch Institut","year":"1999","unstructured":"Robert Koch Institut Annual report on important infectious diseases in Germany. Part 5. Vaccine preventable diseases: diphtheria, tetanus, poliomyelitis, pertussis, measles, mumps, and rubella. Epidemiologisch. Bull. 19 1999 139 143","journal-title":"Epidemiologisch. Bull."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/513825"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1979.02130120032005"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703172961102"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540480052038"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80203-6"},{"key":"e_1_3_2_39_2","first-page":"649","article-title":"Altersabh\u00e4ngige Seropr\u00e4valenz von Masern-, Mumps- und R\u00f6telnantik\u00f6rpern im Jahr 1996.","volume":"128","author":"Z\u00e4ch K.","year":"1998","unstructured":"Z\u00e4ch K. Nicoara C. Germann D. Matter L. Altersabh\u00e4ngige Seropr\u00e4valenz von Masern-, Mumps- und R\u00f6telnantik\u00f6rpern im Jahr 1996. Schweiz. Med. Wochenschr. 128 1998 649 657","journal-title":"Schweiz. Med. Wochenschr."}],"container-title":["Clinical Diagnostic Laboratory Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.6.6.868-871.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.6.6.868-871.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T04:12:12Z","timestamp":1645589532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.6.6.868-871.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["10.1128\/CDLI.6.6.868-871.1999"],"URL":"https:\/\/doi.org\/10.1128\/cdli.6.6.868-871.1999","relation":{},"ISSN":["1071-412X","1098-6588"],"issn-type":[{"value":"1071-412X","type":"print"},{"value":"1098-6588","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]},"assertion":[{"value":"1999-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}